Department of Rehabilitation, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China.
Department of Physical Medicine and Rehabilitation, The Second Clinical College, China Medical University, Shenyang, Liaoning, China.
BMJ Open. 2022 Apr 7;12(4):e058981. doi: 10.1136/bmjopen-2021-058981.
The global cancer burden is a major public health problem. Cancer rehabilitation is an essential component of survivorship care for preventing complications, decreasing symptoms and improving functional quality of life (QOL). In addition to pre-existing challenges, the COVID-19 pandemic has greatly affected cancer rehabilitation programmes and their delivery to patients. This comprehensive systematic review will assess the efficacy and safety of telerehabilitation on functional outcomes and QOL in patients with cancer and survivors.
This study was conducted in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols. The following key electronic bibliographic databases will be searched from their inception to April 2021: MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature, Cochrane Central Register of Controlled Trials and Physiotherapy Evidence Database (PEDro). We will include randomised controlled trials (RCTs) published in English that examine the effects of telerehabilitation programmes on patients with cancer and survivors. The terms 'telerehabilitation', 'neoplasm', 'RCT' and their analogous terms will be used in our search strategy. Two reviewers will independently complete the study screening, selection, data extraction and quality rating. The PEDro scale will be used to assess the methodological quality of the included studies. Narrative or quantitative synthesis will be conducted on the basis of the final data. The planned start and end dates for the study are 1 March 2021 and 1 May 2022, respectively.
Ethical approval will not be required for this review, and the results will be disseminated in peer-reviewed journals.
CRD42021243467.
全球癌症负担是一个主要的公共卫生问题。癌症康复是生存护理的重要组成部分，可预防并发症、减轻症状并改善功能生活质量（QOL）。除了先前存在的挑战外，COVID-19 大流行极大地影响了癌症康复计划及其对患者的实施。本全面系统评价将评估远程康复对癌症患者和幸存者的功能结局和 QOL 的疗效和安全性。
本研究按照系统评价和荟萃分析报告的首选项目进行。将从成立之日起至 2021 年 4 月在以下主要电子书目数据库中进行搜索：MEDLINE、Embase、护理学和联合健康文献累积索引、 Cochrane 对照试验中央注册库和物理治疗证据数据库（PEDro）。我们将纳入以英语发表的随机对照试验（RCT），这些试验研究了远程康复计划对癌症患者和幸存者的影响。搜索策略中将使用“远程康复”、“肿瘤”、“RCT”及其类似术语。两名评审员将独立完成研究筛选、选择、数据提取和质量评分。PEDro 量表将用于评估纳入研究的方法学质量。将根据最终数据进行叙述性或定量综合。研究的计划开始和结束日期分别为 2021 年 3 月 1 日和 2022 年 5 月 1 日。
本综述不需要伦理批准，结果将在同行评议期刊上发表。
PROSPERO 注册号：CRD42021243467。
